Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis

por Bergman, Martin J., Elkin, Eric P., Ogale, Sarika, Kamath, Tripthi, Hamburger, Max I.
Publicado 2014

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

por Curtis, Jeffrey R, van der Helm-van Mil, Annette H, Knevel, Rachel, Huizinga, Tom W, Haney, Douglas J, Shen, Yijing, Ramanujan, Saroja, Cavet, Guy, Centola, Michael, Hesterberg, Lyndal K, Chernoff, David, Ford, Kerri, Shadick, Nancy A, Hamburger, Max, Fleischmann, Roy, Keystone, Edward, Weinblatt, Michael E
Publicado 2012